Oisin Biotechnologies
Seattle
About Oisin Biotechnologies
Oisin Biotechnologies is a platform drug development company focused on creating drugs to combat a variety of age-related diseases. It is developing a highly precise, patent-pending, DNA-targeted intervention to clear these cells. As a recent study has shown, clearing senescent cells both reduces the negative effects of aging pathologies and also extends the median lifespan and survival. Oisin Biotechnologies was founded in 2014 and is headquartered in Seattle, Washington.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $32.1M
- Funding stage: Early Stage Venture
- Last round: Series A (Aug 2025)
- Website: oisinbio.com
- Phone: 206-880-1166
Industries & Categories
Biopharma, Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/oisin-biotechnologies-8971 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.